CUR also has an effect in melanoma and glioblastoma based cancer which was observed via increased autophagy and decreased levels of mitophagy markers, in combination with inhibition of the PI3K-Akt/mTOR pathway when treating of glioblastoma cells [93,94]. Here, MTOR is linked to glioblastoma.